In terms of cancer, IGF2 mRNA-binding protein 2 (Imp2) regulates the activity of IGF2, which further activates PI3K/AKT signaling to promote glioblastoma (GBM) malignancy.32 This evidence concerns the gene AKT1 and cancer.